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mAbstract
Background: Decreased renal blood flow (RBF) and vasoconstriction are considered
major mechanisms of contrast-induced acute kidney injury (CIAKI). To understand the
severity and duration of such putative effects, we measured systemic and renal
hemodynamics after intra-arterial radiocontrast administration. The subjects were six
Merino ewes. The setting was a university-affiliated research institute. This is a
randomized cross-over experimental study.
Methods: Transit-time flow probes were implanted on the pulmonary and left renal
arteries 2 weeks before experimentation. We simulated percutaneous coronary
intervention by administering five intra-arterial boluses of 0.5 mL/kg saline (control) or
radiocontrast (iodixanol) to a total of 2.5 mL/kg over 1 h. Cardiac output (CO), heart rate,
mean arterial pressure (MAP), RBF, renal vascular conductance (RVC), urine output (UO),
creatinine clearance (CrCl), and fractional excretion of sodium (FENa) were measured.
Results: In the first 8 h after intra-arterial administration of radiocontrast, CO, total
peripheral conductance (TPC), and heart rate (HR) increased compared with those
after normal saline administration. Thereafter, CO and TPC were similar between the
two groups, but HR remained higher with radiocontrast (p < 0.001). After a short
(30 min) period of renal vasoconstriction with preserved RBF secondary to an
associated increase in MAP, RBF and RVC showed an earlier and greater increase
(vasodilatation) with radiocontrast (p < 0.001) and remained higher during the first 2
days. Radiocontrast initially increased urine output (p < 0.001) and FENa (p = 0.003).
However, the overall daily urine output decreased in the radiocontrast-treated animals
at 2 days (p < 0.001) and 3 days (p = 0.006). Creatinine clearance was not affected.
Conclusions: In healthy animals, intra-arterial radiocontrast increased RBF, induced
renal vasodilatation, and caused a delayed period of oliguria. Our findings suggest
that sustained reduction in RBF and renal vasoconstriction may not occur in normal
large mammals after intra-arterial radiocontrast administration.
Keywords: Radiocontrast agent; Angiography; Contrast-induced acute kidney injury;
Renal vascular resistance; Vasoconstriction; Renal blood flow; IodixanolBackground
Intra-arterial radiocontrast is used for coronary angiography and/or percutaneous cor-
onary intervention (PCI) worldwide. In at-risk patients, radiocontrast can induce acute
kidney injury (AKI). Such contrast-induced acute kidney injury (CIAKI) is one of the
leading causes of AKI in hospitals [1-7]. CIAKI is independently associated with a
higher mortality rate, hospital stay, and cost of care [3].2014 Calzavacca et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
ttribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any
edium, provided the original work is properly credited.
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and are considered important to the development of CIAKI. One is a direct toxic effect
of radiocontrast on renal tubular cells with ‘osmotic nephrosis’ [8-10], but the patho-
physiological relevance of this is unclear because it has only been described ex vivo and
it does not logically explain changes in glomerular filtration rate (GFR). The other possible
mechanism is a decrease in renal blood flow (RBF) secondary to renal vasoconstriction.
Human, dog, and small-animal studies have reported that intravenous infusion of contrast
media significantly reduces total renal plasma flow [11-14]. However, in these studies, in-
vestigators administered amounts of contrast that exceed current practice, measured RBF
with techniques of limited accuracy, and performed measurements only for a few hours
after radiocontrast administration. The relevance of such findings to a condition which
leads to peak GFR losses at 72 h is open to question. We recently used a validated meth-
odology to measure systemic and renal hemodynamics directly, accurately, and over sev-
eral days by implanted transit-time flow probes [15-17] and found that, contrary to
expectation, intravenous contrast administration induced only short-lived renal vasocon-
striction (first hour) followed by sustained (days) renal vasodilatation and increased RBF
[18]. However, such observations may not apply to the most common trigger of CIAKI:
intra-arterial boluses of radiocontrast given over a short time during PCI.
Accordingly, we studied the effect of intra-arterial radiocontrast in sheep while con-
tinuously measuring renal hemodynamics and repeatedly assessing renal function. We
hypothesized that intra-arterial administration might, unlike intravenous administra-
tion, induce sustained renal vasoconstriction and, thereby, decrease GFR.Methods
Animal preparation
We conducted a randomized cross-over study in six adult Merino ewes (weight 33 ± 1 kg).
The animals were housed in individual metabolic cages, with free access to food and
water. The experimental procedures were approved by the Animal Experimental Ethics
Committee of the Florey Institute of Neuroscience under guidelines laid down by the
National Health and Medical Research Council of Australia.
The animals underwent three sterile surgical procedures under general anesthesia at
intervals of at least 2 weeks. Anesthesia was induced with intravenous sodium thiopen-
tone (10 to 15 mg/kg) for intubation with an endotracheal tube (cuffed size 9). Main-
tenance of anesthesia was by means of oxygen/air/isoflurane (end-tidal isoflurane 1.5%
to 2.0%). Fractional inspired oxygen was altered to maintain SatO2 above 97%, and ven-
tilation was controlled to maintain end-tidal CO2 at approximately 35 mmHg. First, a
bilateral carotid arterial loop was created to facilitate subsequent arterial cannulation.
During the second procedure, a transit-time flow probe (Transonic Systems, Ithaca,
NY, USA) was placed on the pulmonary artery through a left side fourth intercostal
space thoracotomy. Finally, during the third procedure, a transit-time flow probe was
placed on the left renal artery. The animals were allowed to recover at least 2 weeks
from the last surgical procedure before the start of the experiments. In all operations,
the animals were treated with intramuscular antibiotics (900 mg, Ilium Propen, procaine
penicillin, Troy Laboratories Pty Ltd, Smithfield, NSW, Australia, or Mavlab, Slacks
Creek, QLD, Australia) at the start of surgery and then for 2 days post-operatively. Post-
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(1 mg/kg) (Troy Laboratories Pty Ltd or Mavlab) at the start of surgery and then 8 and
24 h post-surgery.
The day before the experiment, a Tygon catheter (Cole-Parmer, Boronia, VIC,
Australia; ID 1.0 mm, OD 1.5 mm, length 80 cm) was inserted into one carotid arterial
loop to measure arterial pressure, to obtain blood samples, and to inject radiocontrast.
The insertion of this catheter was performed under fluoroscopic guidance to confirm
positioning of the catheter in the ascending aorta. Analog signals (mean arterial pres-
sure (MAP), heart rate (HR), cardiac output (CO), and RBF) were collected on a com-
puter using a customized data acquisition system (LabVIEW, National Instruments,
Austin, TX, USA). The data were recorded at 100 Hz for 10 s every minute during ex-
periments. Standard formulae were applied to calculate total peripheral conductance
(TPC = CO/MAP) and renal vascular conductance (RVC = RBF/MAP).
Urine output (UO) was collected hourly through an automated urine fraction
collector at hourly intervals for 5 days (2 days baseline, day 0, and 2 days post-
intervention). Two-hour creatinine clearance (CrCl) and fractional excretion of so-
dium (FENa) were calculated according to standard formulae: CrCl = (UCreat × UO)/
(PCreat/time(min)), where UCreat is urine creatinine, PCreat plasma creatinine, and UO
urine volume in 2 h; FENa = PNa/UNa × CrCl × 100, where PNa is plasma concentration
and UNa urine concentration of sodium.Experimental protocol
Baseline hemodynamic and UO measurements were collected for 48 h prior to the ad-
ministration of control fluid (normal saline) or the radiocontrast agent (iodixanol,
Visipaque™, GE Healthcare, Milwaukee, WI, USA). To replicate a coronary angiogram
study (PCI), we observed several PCIs at our institution and replicated practice in our
model. Thus, normal saline or iodixanol was infused intra-arterially as five boluses of
0.5 mL/kg at 12-min intervals. Blood samples were taken before the start and then at 2,
4, 8, 24, 48, and 72 h after the injections. Urine was collected hourly throughout the ex-
periment from the bladder catheter and sampled in 2-h lots at the predefined time
points for creatinine clearance and fractional excretion of urea measurements up to the
third day after the administration of control or radiocontrast. Bladder catheters were
then removed. The hemodynamic parameters were followed for a total of 5 days after
saline or radiocontrast administration. The animals had free access to food and water
with food given at 5 p.m. every day. However, the day of the injection, fluid and water
were restricted from 8 a.m. to 4 p.m. to avoid confounders on urine output and
hemodynamic variables. Daily water intake was also recorded for every animal.Statistical analysis
All data are presented as means ± standard error of means (SEM) or geometric
means (95% confidence interval) as appropriate. For baseline values, averages of
the 48 h of baseline are presented. Hour-by-hour values for the first 8 h and daily
averages up to the fifth day were compared with the average of baseline values by
analysis of variance. To adjust for multiple comparisons, p < 0.01 was used to indi-
cate significance. Statistical analysis was performed using SAS version 9.2 (SAS
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transformed where appropriate.
Mixed linear modeling was performed with each sheep treated as a random effect.
Main effects were fitted for time and treatment with an interaction between time and
treatment used to determine if treatments behaved differently over time. Specific time
point comparisons were performed using post hoc pairwise t-tests. To account for mul-
tiple comparisons, a reduced p value of 0.01 was considered to be statistically significant.Results
Systemic hemodynamics
In the first 8 h, intra-arterial administration of radiocontrast increased CO, TPC, and HR
more than that of normal saline (Table 1 and Figure 1) without any difference in MAP.
Daily changes in CO and TPC were not different between the two groups (p = 0.10 and
p = 0.30, respectively, for CO and TPC) (Table 2 and Figure 2). MAP was higher at
baseline in the radiocontrast-treated animals and remained higher with radiocontrast
during the following 5 days, with significant differences (p < 0.001) between groups
(Table 2). HR was also higher with radiocontrast (Table 2). The differences between
the groups, although statistically significant, were small and occurred with full preser-
vation of the normal circadian rhythm (Figure 2).Renal hemodynamics
After a short (30 min) period of renal vasoconstriction with preserved RBF secondary
to an associated increase in MAP (Figure 1), in the first 8 h (Table 1 and Figure 1), RBF
and RVC showed an earlier and greater increase in the radiocontrast-treated animals
(p < 0.001) and both RBF and RVC remained higher during the following 2 days (Table
2 and Figure 3). By day 3, RBF and RVC had returned to baseline values. The circadian
rhythms of RBF and RVC were preserved.Renal function
Radiocontrast increased urine output at the first and the second hour (both p < 0.001
compared to baseline) (Figure 3) and FENa at 2 h (p = 0.003 for comparison with base-
line) (Figure 4). Normal saline did not affect urine output, creatinine clearance, or frac-
tional excretion of sodium. Creatinine clearance was not changed at any time point by
radiocontrast administration; however, the overall daily urine output decreased in the
radiocontrast-treated animals after 2 days (p < 0.001) and 3 days (p = 0.006) (Table 2).Discussion
Key findings
We performed an experimental study in conscious large animals to assess the systemic
and renal hemodynamic effects of repeated intra-arterial boluses of radiocontrast, simu-
lating PCI-associated contrast administration. Measurements were taken over 5 days
following administration of contrast, the period when CIAKI typically becomes clinic-
ally manifest. Intra-arterial radiocontrast induced an early and short-lived (hours) in-
crease in heart rate and cardiac output with peripheral vasodilatation. Contrary to our
hypothesis, we found that radiocontrast caused a large increase in renal blood flow and
Table 1 Haemodynamic values at baseline and during the first 8 hours after arterial radiocontrast
GROUP Baseline 1st hour 2nd hour 3rd hour 4th hour 5th hour 6th hour 7th hour 8th hour
CO (L/min) Saline 3.52 (±0.26)* 3.70 (±0.27)° 3.65 (±0.27) 3.46 (±0.27)* 3.35 (±0.27)° 3.36 (±0.27)° 3.23 (±0.27)° 3.12 (±0.27)° 3.35 (±0.27)°
Contrast 3.25 (±0.26)* 3.66 (±0.27)° 3.80 (±0.27)° 3.31 (±0.27)* 3.30 (±0.27) 3.53 (±0.27)° 3.37 (±0.27) 3.32 (±0.27) 3.47 (±0.27)°
HR (bpm) Saline 65 (±4) 66 (±5)* 65 (±5)* 64 (±5) 60 (±5)°* 60 (±5)°* 58 (±5)°* 56 (±5)°* 60 (±5)°*
Contrast 64 (±4) 76 (±5)°* 86 (±5)°* 68 (±5) 67 (±5)* 72 (±5)°* 68 (±5)* 65 (±5)* 69 (±5)°*
MAP (mmHg) Saline 88 (±2)* 87 (±2) 88 (±2) 85 (±2)° 87 (±2) 86 (±2) 87 (±2) 85 (±2)° 86 (±2)
Contrast 95 (±2)* 95 (±2) 95 (±2) 92 (±2)° 91 (±2)° 94 (±2) 93 (±2) 92 (±2)° 93 (±2)
TPC (mL/min/mmHg) Saline 39.8 (±3.0)* 42.2 (±3.0)°* 41.0 (±3.0) 40.4 (±3.0)* 38.3 (±3.0) 38.9 (±3.0) 37.1 (±3.0)° 36.3 (±3.0)° 38.8 (±3.0)
Contrast 35.0 (±3.0)* 39.9 (±3.0)°* 40.3 (±3.0)° 36.3 (±3.0)* 36.7 (±3.0)° 38.4 (±3.0)° 36.5 (±3.0) 36.3 (±3.0) 37.9 (±3.0)°
RBF (mL/min) Saline 167 (±19)* 171 (±19)* 176 (±19)° 181 (±19)°* 177 (±19)°* 170 (±19)* 166 (±19)* 165 (±19)* 166 (±19)*
Contrast 156 (±19)* 157 (±19)* 183 (±19)° 189 (±19)°* 191 (±19)°* 195 (±19)°* 191 (±19)°* 190 (±19)°* 188 (±19)°*
RVC (mL/min/mmHg) Saline 1.83 (±0.19)* 1.96 (±0.19)°* 1.96 (±0.19)° 2.11 (±0.19)° 2.00 (±0.19)°* 1.96 (±0.19)°* 1.90 (±0.19)°* 1.92 (±0.19)°* 1.93 (±0.19)°*
Contrast 1.66 (±0.19)* 1.68 (±0.19)* 1.95 (±0.19)° 2.05 (±0.19)° 2.10 (±0.19)°* 2.12 (±0.19)°* 2.09 (±0.19)°* 2.06 (±0.19)°* 2.04 (±0.19)°*
UO (mL/h) Saline 12 (±8) 30 (±10)* 27 (±10)* 27 (±10) 23 (±10) 25 (±10) 21 (±10) 24 (±10) 25 (±10)
Contrast 17 (±8) 66 (±10)°* 70 (±10)°* 30 (±10) 30 (±10) 16 (±10) 17 (±10) 10 (±10) 15 (±10)





















Figure 1 Hemodynamic changes in the first 8 h after radiocontrast administration. Changes in
systemic and renal hemodynamics from baseline after an intra-arterial bolus of radiocontrast agent or saline.
Values are mean ± SEM at 5-min intervals.
Calzavacca et al. Intensive Care Medicine Experimental 2014, 2:32 Page 6 of 12
http://www.icm-experimental.com/content/2/1/32renal vasodilatation in the first 8 h, which returned to control over 48 h. Functionally,
radiocontrast did not affect creatinine clearance, but caused an early (first 2 h) in-
crease in urine output and FENa followed by a delayed decrease in urine output by
days 2 and 3.Relationship to previous studies
Our experimental findings are unique because of the detailed and prolonged measure-
ment of RBF with highly accurate technology. No such extended studies of the systemic
and renal hemodynamic effects of intra-arterial radiocontrast administration have been
performed. Our findings are at odds with some previous studies which demonstrate vaso-
constriction after contrast medium administration [11-14]. They are, however, in concord-
ance with other work by our group, which found that intravenous radiocontrast induced a
quantitatively dominant and prolonged renal vasodilatation lasting at least 72 h after treat-
ment. They are also in concordance with the only other study that performed some lim-
ited extended monitoring of RBF after radiocontrast administration [19].
If radiocontrast injection also induced vasodilatation and global hyperemia in man, it
might seem counterintuitive that decreased GFR and oliguria would follow, as seen with
CIAKI in at-risk patients. However, glomerular capillary filtration pressure is dependent
on the relationship between afferent and efferent arteriolar tone. If, for example, afferent
Table 2 Haemodynamic values during the first 5 days after radio-contrast injection
GROUP Baseline 1st day 2nd day 3rd day 4th day 5th day
CO (L/min) Saline 3.52 (±0.26)* 3.52 (0.30) 3.41 (0.30)°* 3.29 (0.30)° 3.40 (0.30)° 3.46 (0.30)*
Contrast 3.25 (±0.26)* 3.42 (0.30)° 3.24 (0.30)* 3.18 (0.30) 3.31 (0.30) 3.21 (0.30)*
HR (bpm) Saline 65 (±4) 64 (±4)* 61 (±4)°* 60 (±4)°* 62 (±4)°* 63 (±4)
Contrast 64 (±4) 69(±4)°* 65 (±4)* 64 (±4)* 67 (±4)* 65 (±4)
MAP (mmHg) Saline 88 (±2)* 87 (±1)* 85 (±1)°* 86 (±1)* 84 (±1)°* 86 (±1)*
Contrast 95 (±2)* 93 (±1)°* 92 (±1)°* 91 (±1)°* 89 (±1)°* 89 (±1)°*
TPC (mL/min/mmHg) Saline 39.8 (±3.0)* 40.5 (±3.6)* 39.9 (±3.6)* 38.1 (±3.6)°* 40.6 (±3.6)* 40.2 (±3.6)*
Contrast 35.0 (±3.0)* 37.5 (±3.6)°* 35.6 (±3.6)* 35.3 (±3.6)* 37.8 (±3.6)°* 36.9 (±3.6)°*
RBF (mL/min) Saline 167 (±19)* 171 (±18)* 166 (±18) 163 (±18)* 166 (±18)* 174 (±18)*
Contrast 156 (±19)* 181 (±18)°* 163 (±18)° 153 (±18)* 155 (±18)* 150 (±18)*
RVC (mL/min/mmHg) Saline 1.83 (±0.19)* 1.93 (±0.18)° 1.94 (±0.18)°* 1.88 (±0.18)°* 1.97 (±0.18)°* 2.00 (±0.18)°*
Contrast 1.66 (±0.19)* 1.97 (±0.18)° 1.78 (±0.18)°* 1.69 (±0.18)°* 1.75 (±0.18)* 1.72 (±0.18)°*
UO (mL/h) Saline 20 (±3) 24 (±3) 18 (±3) 16 (±3)
Contrast 20 (±3) 22 (±3) 14 (±3)° 16 (±3)°
Daily UO (mL/24 hours) Saline 380 (262;650)* 535 (341;813) 441 (344;532)* 386 (276;512)
Contrast 543 (162;924)* 529 (534;295) 349 (257;427)* 329 (196;596)*
°: p≤0.01 for within group time comparison with baseline; *: p≤0.01 for between-group comparison.





















Figure 2 Changes in systemic hemodynamics over a 5-day period of observation. Changes in
systemic and renal hemodynamics from baseline after an intra-arterial bolus of radiocontrast agent or saline.
Values are mean ± SEM at hourly intervals.
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with angiotensin-converting enzyme inhibitors), then an increase in renal blood flow
(hyperemia) would occur together with a decrease in intraglomerular capillary pressure,
oliguria (as seen in our animals), and a decrease in GFR (not seen in our healthy animals
or in previously healthy patients). This mechanism may be responsible for the de-
creased GFR of radiocontrast exposure. Studies using selective efferent arteriolar vaso-
constrictors may help clarify the role of this mechanism in the pathogenesis of the
observed vasodilatation.
Implications of study findings
Our findings do not support the view that the functional changes induced by intra-arterial
radiocontrast administration are explained by reduced RBF and/or renal vasoconstriction
as is currently reported and published [20]. They imply that efforts to prevent CIAKI by
administering agents known to induce vasodilatation (low-dose dopamine and/or fenoldo-
pam) are unlikely to be successful and that vasopressor agents that preferentially increase
resistance in the efferent arteriole [19,20] may be more logical.
Strengths and limitations
Our study has several strengths. First, we measured RBF and renal vascular conduct-
ance continuously with highly accurate technology, every minute for an extended
period of observation. Second, we created a model which simulated the observed practice
of intra-arterial radiocontrast administration as delivered in the cardiac catheterization
Figure 3 Changes in renal hemodynamics over a 5-day period of observation. Changes in systemic
and renal hemodynamics from baseline after an intra-arterial bolus of radiocontrast agent or saline. Values
are mean ± SEM at hourly intervals.
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clinical level. Third, we combined systemic and renal hemodynamics with some measures
of renal function.
However, our experimental study also has several limitations. We studied a specific
radiocontrast agent and our findings may not apply to different agents. We studied a
specific species which may not be representative of effects in other animals, including
man. We used normal animals and our model did not induce a decrease in GFR. Thus,
it is uncertain how these findings may apply in the setting of contrast-induced
Figure 4 Renal functional changes after radiocontrast administration. (a) Creatinine clearance and
(b) fractional excretion of sodium after an intra-arterial bolus of radiocontrast agent or saline. Values are
mean ± SEM. Asterisk indicates p ≤ 0.01 for between-group comparison.
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functional outcomes. We were unable to assess tubular injury, which may be an im-
portant mechanism leading to subsequent loss of GFR. We did not measure GFR with
sophisticated and sensitive techniques. Thus, changes in GFR may have occurred and
have been missed. However, the clinical significance of such changes (if present) would
remain unclear. We did not measure biomarkers of tubular injury [21], but our re-
search focus was on the systemic and renal hemodynamic effects of radiocontrast and
the relevance of such biomarkers remains unclear [22,23]. We did not obtain biopsies
to ascertain the degree of apoptosis or histological injury. However, in order to conduct
the experiments to 5 days, we were not able to perform post-mortem studies and did
not want to affect hemodynamic measurements by any damage that biopsy might have
induced. Moreover, our measurements apply to global renal blood flow and do not pro-
vide information on changes in the renal microvasculature which might have diverted
blood to either the cortex or the medulla and caused medullary hypoxia as shown in ani-
mal models by blood oxygen level-dependent (BOLD) MRI-based techniques [24-26]. We
also acknowledge that there is substantial evidence that contrast agents decrease medul-
lary perfusion and oxygenation. For instance, BOLD MRI studies showed declining me-
dullary oxygenation in healthy individuals [27]; contrast media lead to pimonidazole
Calzavacca et al. Intensive Care Medicine Experimental 2014, 2:32 Page 11 of 12
http://www.icm-experimental.com/content/2/1/32immunostaining and stabilize medullary HIF to a moderate extent, even without COX or
NOS inactivation [28], particularly in the presence of predisposing factors, such as dia-
betes [29]. Furthermore, at least one study found tubuloglomerular feedback (TGF) acti-
vation when contrast media were flushed through the medullary thick ascending loop of
Henle/macula densa [30], providing evidence for a tubular process causing loss of GFR.
Our study does not address any of these possible mechanisms of injury. Finally, data such
as tissue hypoxia [31], declining medullary flows [32], or urine NGAL release [33] suggest
that renal medullary hypoperfusion and parenchymal injury conceivably take place at the
very early period after the injection of radiocontrast. It remains uncertain, however,
whether such a large body of observed pathophysiological events truly contributes to AKI
or represents a constellation of epiphenomena.
Conclusions
In an experimental study extended over 5 days, we found that intra-arterial radiocon-
trast increased renal blood flow and induced renal vasodilatation. This effect was
marked in the first 8 h and persisted for approximately 48 h. Our findings suggest that
sustained reduction in RBF and renal vasoconstriction may not occur in normal large
mammals after intra-arterial radiocontrast administration.
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